Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 4/2009

01.08.2009 | ORIGINAL ARTICLE

Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process

verfasst von: H. Hůlková, J. Ledvinová, H. Poupětová, A. Kohout, V. Malinová, M. Elleder

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Summary

We report a female patient with Gaucher disease (GD) type I on ERT (imiglucerase) for 5 years, which led to a significant general improvement. Aged 59 years she underwent an episode of altitude sickness followed by sepsis, disseminated intravascular coagulation, and multiorgan failure. She succumbed to a cerebral haemorrhage. Autopsy revealed liver cholestatic cirrhosis and multifocal liver carcinoma with immunophenotype compatible with cholangiocarcinoma. Analysis of the storage process revealed its absence or very low levels in the majority of liver and spleen macrophages. Gaucher cells (GCs) were seen only as occasional aggregates of various sizes in these organs. GCs were seen also in the leptomeninx of the cerebellum and as infrequent perivascular clusters in both the grey and white cerebral matters. Bone marrow was heavily infiltrated with GCs, especially in the adipocyte-rich part. GCs in this location displayed varied degrees of cytoplasmic vacuolation unrelated to the lysosomal compartment, caused by droplets of triglyceride, and interpreted as due to resorption of fragments of altered white adipocytes. All these observations point to the relative efficacy of ERT in covering the standard substrate load, which should not be exceeded as it would lead to the evolution of mature GCs. The results are discussed in relation to our recently published hypothesis on GD cell pathology.
Literatur
Zurück zum Zitat Blanchette-Mackie EJ, Briggs T, Chernick, SS et al. (1986) Lipolysis of serum-activated triacylglycerol at the surface of J774.1 macrophages. A biochemical––electron-microscopic study. Cell Tissue Res 244(1):95–105. doi:10.1007/BF00218386 PubMedCrossRef Blanchette-Mackie EJ, Briggs T, Chernick, SS et al. (1986) Lipolysis of serum-activated triacylglycerol at the surface of J774.1 macrophages. A biochemical––electron-microscopic study. Cell Tissue Res 244(1):95–105. doi:10.​1007/​BF00218386 PubMedCrossRef
Zurück zum Zitat Brady RO, King FM (1973) Gaucher’s Diseasedisease. In: Hers HG, Van Hoof F, eds. Lysosomes and storage Storage diseasesDiseases. New York: Academic Press, 381–394. Brady RO, King FM (1973) Gaucher’s Diseasedisease. In: Hers HG, Van Hoof F, eds. Lysosomes and storage Storage diseasesDiseases. New York: Academic Press, 381–394.
Zurück zum Zitat Brady RO, Pentchev PG, Gal AE, et al. (1974) Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher’s Gaucher’s disease. N Engl J Med 291(19):989–993.PubMedCrossRef Brady RO, Pentchev PG, Gal AE, et al. (1974) Replacement therapy for inherited enzyme deficiency. Use of purified glucocerebrosidase in Gaucher’s Gaucher’s disease. N Engl J Med 291(19):989–993.PubMedCrossRef
Zurück zum Zitat Breiden-Langen CM, Buchsel R, Brambs HJ, et al. (1991) Coincidence of Gaucher disease with primary hepatocellular carcinoma]. Leber Magen Darm 21(3):126, 129–130. Breiden-Langen CM, Buchsel R, Brambs HJ, et al. (1991) Coincidence of Gaucher disease with primary hepatocellular carcinoma]. Leber Magen Darm 21(3):126, 129–130.
Zurück zum Zitat Conradi NG, Kalimo H, Sourander P (1988) Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease. Acta Neuropathol 75(4):385–390. doi:10.1007/BF00687792 PubMedCrossRef Conradi NG, Kalimo H, Sourander P (1988) Reactions of vessel walls and brain parenchyma to the accumulation of Gaucher cells in the Norrbottnian type (type III) of Gaucher disease. Acta Neuropathol 75(4):385–390. doi:10.​1007/​BF00687792 PubMedCrossRef
Zurück zum Zitat Daniels LB, Glew RH, Radin NS, et al. (1980) A revised fluorometric assay for Gaucher’s Gaucher’s disease using conduritol-beta-epoxide with liver as the source of Betabeta-glucosidase. Clin Chim Acta 106(2):155–163. doi:10.1016/0009-8981(80)90168-0 PubMedCrossRef Daniels LB, Glew RH, Radin NS, et al. (1980) A revised fluorometric assay for Gaucher’s Gaucher’s disease using conduritol-beta-epoxide with liver as the source of Betabeta-glucosidase. Clin Chim Acta 106(2):155–163. doi:10.​1016/​0009-8981(80)90168-0 PubMedCrossRef
Zurück zum Zitat Daniels LB, Coyle PJ, Glew RH, et al. (1982) Brain glucocerebrosidase in Gaucher’s Gaucher’s disease. Arch Neurol 39(9):550–556PubMed Daniels LB, Coyle PJ, Glew RH, et al. (1982) Brain glucocerebrosidase in Gaucher’s Gaucher’s disease. Arch Neurol 39(9):550–556PubMed
Zurück zum Zitat Desnick RJ, Gatt S, Grabowski GA (1982) Progress in Clinical and Biological Research. Gaucher Disease: A Century of Delineation and Research. New York: Alan R. Liss Desnick RJ, Gatt S, Grabowski GA (1982) Progress in Clinical and Biological Research. Gaucher Disease: A Century of Delineation and Research. New York: Alan R. Liss
Zurück zum Zitat Elleder M (2006) Glucosylceramide transfer from lysosomes–the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data. J Inherit Metab Dis 29(6):707–715. doi:10.1007/s10545-006-0411-z PubMedCrossRef Elleder M (2006) Glucosylceramide transfer from lysosomes–the missing link in molecular pathology of glucosylceramidase deficiency: a hypothesis based on existing data. J Inherit Metab Dis 29(6):707–715. doi:10.​1007/​s10545-006-0411-z PubMedCrossRef
Zurück zum Zitat Goldstein JL, Hobbs HH, Brown MS (2001) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2863–2914 Goldstein JL, Hobbs HH, Brown MS (2001) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D eds; Childs B, Kinzler KW, Vogelstein B, assoc. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2863–2914
Zurück zum Zitat Hill SC, Reinig JW, Barranger JA, et al. (1986) Gaucher disease: sonographic appearance of the spleen. Radiology 160(3):631–634.PubMed Hill SC, Reinig JW, Barranger JA, et al. (1986) Gaucher disease: sonographic appearance of the spleen. Radiology 160(3):631–634.PubMed
Zurück zum Zitat Keslova-Veselikova J, Hulkova H, Dobrovolny R, et al. (2008) Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients. Virchows Arch 452(6):651–665. doi:10.1007/s00428-008-0586-9 PubMedCrossRef Keslova-Veselikova J, Hulkova H, Dobrovolny R, et al. (2008) Replacement of alpha-galactosidase A in Fabry disease: effect on fibroblast cultures compared with biopsied tissues of treated patients. Virchows Arch 452(6):651–665. doi:10.​1007/​s00428-008-0586-9 PubMedCrossRef
Zurück zum Zitat Leinekugel P, Michel S, Conzelmann E et al. (1992) Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88(5):513–523. doi:10.1007/BF00219337 PubMedCrossRef Leinekugel P, Michel S, Conzelmann E et al. (1992) Quantitative correlation between the residual activity of beta-hexosaminidase A and arylsulfatase A and the severity of the resulting lysosomal storage disease. Hum Genet 88(5):513–523. doi:10.​1007/​BF00219337 PubMedCrossRef
Zurück zum Zitat Markwell MA, Haas SM, Tolbert NE, et al. (1981) Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol 72:296–303.PubMedCrossRef Markwell MA, Haas SM, Tolbert NE, et al. (1981) Protein determination in membrane and lipoprotein samples: manual and automated procedures. Methods Enzymol 72:296–303.PubMedCrossRef
Zurück zum Zitat Wenger DA, Williams C (1991) Screening for Lysosomal lysosomal Disordersdisorders. In: Hommes FA, eds. Techniques in Diagnostic Human Biochemical Genetics. New York: Willey-Liss, 587–617. Wenger DA, Williams C (1991) Screening for Lysosomal lysosomal Disordersdisorders. In: Hommes FA, eds. Techniques in Diagnostic Human Biochemical Genetics. New York: Willey-Liss, 587–617.
Metadaten
Titel
Autopsy case of Gaucher disease type I in a patient on enzyme replacement therapy. Comments on the dynamics of persistent storage process
verfasst von
H. Hůlková
J. Ledvinová
H. Poupětová
A. Kohout
V. Malinová
M. Elleder
Publikationsdatum
01.08.2009
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 4/2009
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-009-1178-9

Weitere Artikel der Ausgabe 4/2009

Journal of Inherited Metabolic Disease 4/2009 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.